share_log

奥赛康(002755.SZ)发布上半年业绩,扭亏为盈至7559.45万元

Beijing Aosaikang Pharmaceutical (002755.SZ) has announced its performance for the first half of the year, turning a loss into a profit of 75.5945 million yuan.

Zhitong Finance ·  Aug 29, 2024 04:12

Beijing Aosaikang Pharmaceutical (002755.SZ) released its semi-annual report for 2024. During the reporting period, the company achieved revenue of 9 billion yuan...

ZhItong Finance APP News, Beijing Aosaikang Pharmaceutical (002755.SZ) released its semi-annual report for 2024. During the reporting period, the company achieved revenue of 0.923 billion yuan, a year-on-year growth of 29.60%. The net income attributable to shareholders of the listed company was 75.5945 million yuan. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 55.1349 million yuan. The earnings per share were 0.08 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment